Company page

Globeimmune Inc

Globeimmune Inc (ticker: GBIM) is a public company based in the United States, focusing on developing innovative immunotherapy treatments. With a market capitalization of $6 million, the company is engaged in advancing its proprietary technologies to address unmet medical needs. Globeimmune aims to leverage its expertise in immunology to create effective therapies for various diseases.